Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Collins GP"" wg kryterium: Autor


Wyświetlanie 1-1 z 1
Tytuł:
RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial.
Autorzy:
Lim SH; Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
Linton KM; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Cancer Research Centre, Southampton, UK.
Collins GP; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Dhondt J; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK. .
Caddy J; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
Rossiter L; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
Vadher K; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
Fines K; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
Rogers LE; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
Fernando D; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
Stanton L; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
Davies AJ; ECMC Southampton, University of Southampton, Southampton, UK.
Johnson PWM; CRUK Centre Southampton, University of Southampton, Southampton, UK.
Griffiths G; Southampton Clinical Trials Unit, Centre for Cancer Immunology, University of Southampton, Southampton, UK.
Pokaż więcej
Źródło:
Trials [Trials] 2018 Nov 09; Vol. 19 (1), pp. 619. Date of Electronic Publication: 2018 Nov 09.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Randomized Controlled Trials as Topic*
Antibodies, Monoclonal/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Lymphoma, Large B-Cell, Diffuse/*drug therapy
Rituximab/*administration & dosage
Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Clinical Trials, Phase II as Topic ; Humans ; Multicenter Studies as Topic ; Rituximab/adverse effects ; Sample Size
Czasopismo naukowe
    Wyświetlanie 1-1 z 1

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies